One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Blood Collection Market

[ 英語タイトル ] Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022


Product Code : MNMHC00109030
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“Global blood collection market projected to grow at CAGR of 5.5%.”
The global blood collection market is projected to reach USD 10.59 billion by 2022 from USD 8.10 billion in 2017, growing at a CAGR of 5.5% during the forecast period. The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products. However, the high cost associated with automated blood collection devices is expected to restrain market growth to a certain extent.

“The blood collection devices segment is expected to grow at the highest rate during the forecast period.”
On the basis of product, the market is broadly segmented into blood collection tube, needles and syringes, blood bags, blood collection device, and lancets. During the forecast period, blood collection devices segment is expected to grow at the highest CAGR. Growth in the blood collection devices segment is driven by the growing prevalence of blood disorders, increasing demand for plasma from biopharmaceutical companies for plasma fractionation, and rising demand for apheresis & whole blood collection devices in blood banks in emerging countries.

“The automated blood collection to grow at the highest CAGR during the forecast period.”
By method, the market is classified into manual blood collection and automated blood collection. The automated blood collection segment is expected to register the highest CAGR during the forecast period. Growth in this segment is attributed to the increasing demand for safer procedures to withdraw and separate blood components for transfusion; availability of advanced blood collecting products; and the rising demand for plasma by biopharmaceutical companies.

“The APAC region is expected to grow at the highest CAGR over the next five years.”
North America held the largest share of the global blood collection market in 2016, while Asia Pacific (APAC) is expected to witness the highest growth during the forecast period. A large population base, improving healthcare infrastructure, growing medical tourism, increasing number of hospitals, and rising disposable incomes in the region are expected to offer significant growth opportunities for key players operating in the market.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–40%, Tier 2–30%, and Tier 3–30%
• By Designation – C-level–27%, Director Level–18%, and Others–55%
• By Region – North America–50%, Europe–20%, Asia Pacific–20%, and RoW–10%

BD (US), Medtronic (US), and Terumo (Japan) dominated the blood collection market. Some of the other players competing in this market are Haemonetics (US), Fresenius (Germany) Nipro Medical (US), Kawasumi Laboratories (Japan), F.L. Medical (Italy), Greiner Holding (Austria), and Grifols (Spain).

Research Coverage:
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and challenges). The report also offers market sizes and data on the growth of various segments of the industry. It focuses on emerging and high-growth segments, and high-growth regions. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the blood collection market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global blood collection market
• Product/Service Enhancement/Innovation: Detailed insights on upcoming trends and new product/service launches in the global blood collection market
• Market Development: Comprehensive information about the lucrative emerging markets by type of product, method, and region
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global blood collection market
• Competitive Assessment: In-depth assessment of market shares/rank, growth strategies, products, services, and capabilities of leading players in the global market

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.2.1 MARKETS COVERED 14
1.2.2 YEARS CONSIDERED FOR THE STUDY 14
1.3 CURRENCY 15
1.4 LIMITATIONS 15
1.5 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 PRIMARY DATA 17
2.1.1 KEY DATA FROM PRIMARY SOURCES 17
2.1.2 KEY INDUSTRY INSIGHTS 18
2.2 SECONDARY DATA 19
2.2.1 KEY DATA FROM SECONDARY SOURCES 19
2.3 MARKET SIZE ESTIMATION 19
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.4.1 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 BLOOD COLLECTION: MARKET OVERVIEW 27
4.2 EUROPE: BLOOD COLLECTION MARKET, BY END USER (2017) 28
4.3 BLOOD COLLECTION MARKET, BY PRODUCT, 2017 VS. 2022 (USD BILLION) 29
4.4 BLOOD COLLECTION MARKET, BY END USER 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
5.2.1 DRIVERS 31
5.2.1.1 Increasing disease incidence and growing number of accident & trauma cases 31
5.2.1.2 Emergence of liquid biopsy tests 31
5.2.1.3 Rising demand for blood components 31
5.2.2 RESTRAINT 32
5.2.2.1 High cost of automated blood collection devices 32

5.2.3 OPPORTUNITY 32
5.2.3.1 Technological advancements in blood collection procedures and products 32
5.2.4 CHALLENGE 33
5.2.4.1 Lack of skilled professionals 33
6 BLOOD COLLECTION MARKET, BY PRODUCT 34
6.1 INTRODUCTION 35
6.2 BLOOD COLLECTION TUBES 35
6.2.1 SERUM TUBES 37
6.2.2 PLASMA/WHOLE BLOOD TUBES 38
6.2.2.1 EDTA tubes 40
6.2.2.2 Heparin tubes 41
6.2.2.3 Coagulation tubes 42
6.2.2.4 Glucose tubes 42
6.2.2.5 Erythrocyte sedimentation rate (ESR) tubes 43
6.3 NEEDLES & SYRINGES 44
6.4 BLOOD BAGS 45
6.5 BLOOD COLLECTION DEVICES 47
6.6 LANCETS 48
7 BLOOD COLLECTION MARKET, BY METHOD 50
7.1 INTRODUCTION 51
7.2 MANUAL BLOOD COLLECTION 51
7.3 AUTOMATED BLOOD COLLECTION 53
8 BLOOD COLLECTION MARKET, BY END USER 55
8.1 INTRODUCTION 56
8.2 HOSPITALS AND PATHOLOGY LABORATORIES 56
8.3 BLOOD BANKS 58
8.4 OTHER END USERS 60
9 BLOOD COLLECTION MARKET, BY REGION 62
9.1 INTRODUCTION 63
9.2 NORTH AMERICA 64
9.2.1 US 68
9.2.2 CANADA 70
9.3 EUROPE 73
9.3.1 GERMANY 75
9.3.2 FRANCE 77
9.3.3 UK 79
9.3.4 REST OF EUROPE 81

9.4 ASIA PACIFIC 83
9.5 REST OF THE WORLD 87
10 COMPETITIVE LANDSCAPE 89
10.1 MARKET OVERVIEW 89
10.2 MARKET RANKING ANALYSIS, 2016 89
10.3 COMPETITIVE SITUATION AND TRENDS 90
10.3.1 PRODUCT LAUNCHES & APPROVAL 90
10.3.2 ACQUISITIONS 90
10.3.3 AGREEMENTS 91
10.3.4 OTHER DEVELOPMENTS 91
11 COMPANY PROFILES 92
(BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS AND SWOT ANALYSIS.)*
11.1 BECTON, DICKINSON AND COMPANY 92
11.2 MEDTRONIC 95
11.3 TERUMO CORPORATION 98
11.4 HAEMONETICS 101
11.5 FRESENIUS 104
11.6 NIPRO MEDICAL CORPORATION 107
11.7 F.L. MEDICAL 109
11.8 GREINER HOLDING 110
11.9 SMITHS GROUP 113
11.10 GRIFOLS 115
11.11 KAWASUMI LABORATORIES 117
11.12 QUEST DIAGNOSTICS 119
11.13 SARSTEDT 121
11.14 RETRACTABLE TECHNOLOGIES 122
11.15 AB MEDICAL 123
*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments and Swot Analysis, Key relationships might not be captured in case of unlisted companies.
12 APPENDIX 124
12.1 INSIGHTS OF INDUSTRY EXPERTS 124
12.2 DISCUSSION GUIDE 125
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 127
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 129
12.5 AVAILABLE CUSTOMIZATIONS 131
12.6 RELATED REPORTS 132
12.7 AUTHOR DETAILS 133

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+